Clinical Trials:

Retina Associates of South Texas has a history of commitment to participating in clinical trials in order to provide our patients access to new, state-of-the-art therapeutic treatments. Our goal is to provide patients the opportunity to participate in clinical trials of new treatments for retinal diseases. We have partnered with leading pharmaceutical companies, the National Eye Institute and other clinical practices to seek solutions to many retinal conditions.

Participation in a clinical trial is completely voluntary. Eligibility for enrollment into a particular trial is determined through a screening process that varies from study to study. Because of the specific nature of your disease, you may not be eligible for participation. If you decide not to participate or are deemed ineligible, the physicians at Retina Associates will continue to care for your eyes and provide you with the highest standard of care available.

We strive to ensure that our study patients experience the best medical care possible. It is easy for patients to participate successfully in our studies and make informed decisions about their condition. Feel free to contact us to determine if you may be eligible for a study.  The following clinical trials are currently enrolling at Retina Associates of South Texas. If you are interested in being screened for one of our trials, please contact our Study Coordinator at 210-615-7600. 

Currently Enrolling Clinical Trials:

           NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY

  • Bayer NAION - A prospective case crossover study to assess whether PDE5 inhibitor exposure in men with erectile dysfunction increase the risk of the development of non-artertic anterior ischemic optic neuropathy (NAION)

Current Trials:

          DIABETIC RETINOPATHY

  • Genentech RIDE - A study of intravitreal Lucentis (ranibizumab) to treat macular edema due to diabetic retinopathy

          AGE RELATED MACULAR DEGENERATION

  • Genetech HARBOR - a study of intravitreal Lucentis (ranibizumab) to treat macular edema due to subfoveal neovascular age related macular degeneration

Past Clinical Trials:

         DIABETIC RETINOPATHY

  • MacuSight  DR-002
  • Alcon C-07-43

    RETINAL VEIN OCCLUSION
  • Genentech BRAVO
  • Genentech CRUISE

          AGE-RELATED MACULAR DEGENERATION

  • Visudyne (verteporfin) for AMD
  • Macugen (pegaptanib) for AMD - LEVEL
  • Lucentis for AMD - ANCHOR, PIER, SAILOR

          RETINOPATHY OF PREMATURITY

  • CRYO-ROP
  • LIGHT-ROP
  • ET-ROP

          OCULAR TUMOR

  •  Collaborative Ocular Melanoma Study
 
         
   
 

HOME   l   WELCOME   l   LOCATIONS   l   CONTACT US   l   PHYSICIANS
YOUR VISIT   l   YOUR SURGERY   l   INSURANCE   l   FOR PATIENTS   l   CLINICAL TRIALS

 
     
 

San Antonio Office: 210.615.7600     l     Laredo Office:  956.722.5200

 
  2013 Retina Associates of South Texas, All Rights Reserved